Present Scenario of Bioconjugates in Cancer Therapy

Present Scenario of Bioconjugates in Cancer Therapy

A Review. Wadhawan A, Chatterjee M, Singh G. International journal of molecular sciences. 2019 Jan;20(21):5243. [Impact Factor 4.6]

by Dr. Gurpal Singh | UIPS | Contact vendor

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Dr. Gurpal Singh | UIPS

Qualification: M.Pharm, Ph.D (IIT Delhi) Expertise: My research domains include Cancer Theranostics, Lateral Flow Detection Technology, Nanobiosensor, Nanotechnology and Nanobiotechnology: Conjugation of variegated ligands viz aptamer, peptide, antibodies, folic acid and PNA to various types of Quantum Dots (CdSe/ZnS, CdSe/CdS/ZnS, CdSe/ZnSe/ZnS, CdTe, Graphene and Indium Phosphide) and Arduino Uno based Biosensor for detection of E.coli. Experience: I have been working as UGC Assistant Professor at UIPS Panjab University Chandigarh for 4.5 years. Before joining faculty position he worked at Serum Institute of India, a vaccine manufacturing company, Pune and Jagsonpal Pharmaceuticals, Faridabad as research scientist, 1mg.com as a drug information specialist and Pluss App Gurgaon as a Head, Medical Affair. My current research lab is funded by UGC, DST, ICMR, DFRL (DRDO) and DBT.

Need Help? Contact Us Leave Feedback

Category: